Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYVJRR92
Stock Name / FundiShares MSCI USA SRI UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSUUS(GBX) LSE
ETF TickerQDVR(EUR) F
ETF TickerQDVR.DE(EUR) CXE
ETF TickerSUAS.LS(USD) CXE
ETF TickerSUASz(USD) CXE
ETF TickerSUAU.AS(EUR) CXE
ETF TickerSUAS(EUR) ETF Plus
ETF TickerSUAU(EUR) Euronext Amsterdam
ETF TickerSUUS.L(GBP) LSE

Holdings detail for EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

Show aggregate EW holdings

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Key PointsKen Griffin founded the hedge fund firm Citadel. - 2025-09-09 12:44:48
Top Stock Reports for Apple, Novartis & Charles Schwab
Apple grows Services to 1B+ paid subscribers, while Novartis lifts guidance and Schwab rides higher rates to asset gains. - 2025-09-04 17:29:00
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 13:25:48
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 12:26:28
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 09:49:10
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 08:57:30
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 07:43:41
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 04:16:07
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
S&P 500 and Nasdaq 100 Post Record Highs on Earnings Optimism
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. September E-mini S&P futures (ESU25 ) rose +0.38%, and September E-mini Nasdaq futures (NQU25... - 2025-07-28 02:37:03
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 19:42:53
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:56:19
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 14:23:43
Solid Corporate Earnings Results Support Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.18%, and September E-mini Nasdaq futures... - 2025-07-25 14:18:44
Positive Earnings Results Lift Stocks
The S&P 500 Index ($SPX ) (SPY ) today is up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. September E-mini S&P futures (ESU25 ) are up +0.10%, and September E-mini Nasdaq futures... - 2025-07-25 12:39:11
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07

iShares MSCI USA SRI UCITS ETF USD (Acc) EW holdings

DateNumber of EW Shares HeldBase Market Value of EW SharesLocal Market Value of EW SharesChange in EW Shares HeldChange in EW Base ValueCurrent Price per EW Share HeldPrevious Price per EW Share Held
2025-10-01 (Wednesday)168,738USD 12,876,397USD 12,876,397
2025-09-30 (Tuesday)168,738USD 13,122,754EW holding increased by 97868USD 13,122,7540USD 97,868 USD 77.77 USD 77.19
2025-09-29 (Monday)168,738USD 13,024,886EW holding increased by 158613USD 13,024,8860USD 158,613 USD 77.19 USD 76.25
2025-09-26 (Friday)168,738EW holding decreased by -248USD 12,866,273EW holding increased by 146697USD 12,866,273-248USD 146,697 USD 76.25 USD 75.27
2025-09-25 (Thursday)168,986USD 12,719,576EW holding increased by 103081USD 12,719,5760USD 103,081 USD 75.27 USD 74.66
2025-09-24 (Wednesday)168,986EW holding decreased by -268USD 12,616,495EW holding decreased by -1391USD 12,616,495-268USD -1,391 USD 74.66 USD 74.55
2025-09-18 (Thursday)169,254EW holding decreased by -250USD 12,617,886EW holding decreased by -128815USD 12,617,886-250USD -128,815 USD 74.55 USD 75.2
2025-09-17 (Wednesday)169,504USD 12,746,701EW holding increased by 18646USD 12,746,7010USD 18,646 USD 75.2 USD 75.09
2025-09-16 (Tuesday)169,504USD 12,728,055EW holding decreased by -162724USD 12,728,0550USD -162,724 USD 75.09 USD 76.05
2025-09-15 (Monday)169,504USD 12,890,779EW holding decreased by -257646USD 12,890,7790USD -257,646 USD 76.05 USD 77.57
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EW by Blackrock for IE00BYVJRR92

Show aggregate share trades of EW

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-26SELL-248 76.250* 73.61 Profit of 18,254 on sale
2025-09-24SELL-268 74.660* 73.59 Profit of 19,723 on sale
2025-09-18SELL-250 74.550* 73.59 Profit of 18,397 on sale
2025-09-10BUY238 78.280* 73.48
2025-09-08SELL-1,230 80.210* 73.40 Profit of 90,287 on sale
2025-09-04SELL-2,480 80.960* 73.36 Profit of 181,933 on sale
2025-08-06SELL-1,016 78.610* 73.13 Profit of 74,302 on sale
2025-08-04SELL-254 80.090* 73.05 Profit of 18,555 on sale
2025-07-31SELL-254 79.310* 72.98 Profit of 18,536 on sale
2025-07-30SELL-1,651 81.160* 72.93 Profit of 120,400 on sale
2025-07-29SELL-889 80.470* 72.88 Profit of 64,789 on sale
2025-07-28SELL-1,143 78.490* 72.84 Profit of 83,260 on sale
2025-07-18BUY122 76.490* 72.80
2025-07-17BUY127 76.180* 72.78
2025-07-16SELL-1,016 76.140* 72.75 Profit of 73,918 on sale
2025-07-15SELL-762 76.810* 72.73 Profit of 55,418 on sale
2025-07-11BUY504 78.050* 72.66
2025-07-10BUY756 78.800* 72.62
2025-07-09SELL-630 77.190* 72.59 Profit of 45,729 on sale
2025-07-08SELL-3,428 76.390* 72.56 Profit of 248,737 on sale
2025-06-30BUY2,708 78.210* 72.40
2025-06-27SELL-1,612 78.210* 72.36 Profit of 116,650 on sale
2025-06-26SELL-124 77.150* 72.33 Profit of 8,969 on sale
2025-06-24SELL-313 75.850* 72.27 Profit of 22,621 on sale
2025-06-20SELL-2,529 73.830* 72.24 Profit of 182,693 on sale
2025-06-17SELL-5,285 73.270* 72.21 Profit of 381,608 on sale
2025-06-13SELL-620 75.150* 72.16 Profit of 44,742 on sale
2025-06-12BUY595 75.890* 72.14
2025-06-09SELL-1,364 76.360* 72.05 Profit of 98,276 on sale
2025-06-06SELL-357 77.520* 72.01 Profit of 25,707 on sale
2025-06-04SELL-2,337 77.850* 71.92 Profit of 168,068 on sale
2025-06-03SELL-615 77.720* 71.87 Profit of 44,200 on sale
2025-05-30BUY4,985 78.220* 71.77
2025-05-27SELL-120 76.220* 71.64 Profit of 8,597 on sale
2025-05-23SELL-1,560 74.990* 71.59 Profit of 111,674 on sale
2025-05-21SELL-600 76.100* 71.52 Profit of 42,912 on sale
2025-05-19SELL-228 78.040* 71.41 Profit of 16,281 on sale
2025-05-15SELL-240 76.880* 71.30 Profit of 17,112 on sale
2025-05-14SELL-240 76.750* 71.25 Profit of 17,101 on sale
2025-05-13SELL-120 75.500* 71.21 Profit of 8,546 on sale
2025-05-12SELL-360 74.800* 71.18 Profit of 25,626 on sale
2025-05-09SELL-117 73.680* 71.16 Profit of 8,326 on sale
2025-05-08SELL-1,440 74.630* 71.13 Profit of 102,423 on sale
2025-05-01SELL-3 75.180* 70.93 Profit of 213 on sale
2025-04-30SELL-960 75.490* 70.89 Profit of 68,050 on sale
2025-04-28SELL-4,680 75.540* 70.79 Profit of 331,275 on sale
2025-04-25BUY600 76.040* 70.73
2025-04-23SELL-242 70.460* 70.69 Profit of 17,107 on sale
2025-04-17BUY120 71.530* 70.69
2025-04-14SELL-240 69.870* 70.69 Profit of 16,966 on sale
2025-04-11BUY2,828 69.400* 70.71
2025-04-10SELL-119 68.260* 70.73 Profit of 8,417 on sale
2025-04-09BUY357 69.900* 70.74
2025-04-08SELL-345 67.070* 70.79 Profit of 24,421 on sale
2025-04-07SELL-1,404 69.000* 70.81 Profit of 99,413 on sale
2025-04-04SELL-1,170 69.360* 70.82 Profit of 82,864 on sale
2025-04-02SELL-2,102 72.050* 70.81 Profit of 148,841 on sale
2025-03-31SELL-351 72.480* 70.78 Profit of 24,842 on sale
2025-03-28BUY238 70.910* 70.77
2025-03-27SELL-15 71.190* 70.77 Profit of 1,062 on sale
2025-03-26BUY357 71.090* 70.76
2025-03-25BUY595 71.240* 70.76
2025-03-21SELL-595 70.460* 70.75 Profit of 42,099 on sale
2025-03-20SELL-119 70.950* 70.75 Profit of 8,419 on sale
2025-03-19SELL-595 70.900* 70.75 Profit of 42,096 on sale
2025-03-18SELL-357 70.340* 70.76 Profit of 25,260 on sale
2025-03-14SELL-595 69.290* 70.78 Profit of 42,113 on sale
2025-03-13SELL-2,718 67.950* 70.82 Profit of 192,486 on sale
2025-03-12SELL-119 68.510* 70.85 Profit of 8,432 on sale
2025-03-11SELL-705 68.390* 70.89 Profit of 49,977 on sale
2025-03-07SELL-3,205 70.330* 70.93 Profit of 227,346 on sale
2025-03-05SELL-354 72.850* 70.90 Profit of 25,100 on sale
2025-03-03BUY1,180 71.390* 70.89
2025-02-28SELL-25,210 71.620* 70.88 Profit of 1,786,819 on sale
2025-02-27SELL-238 71.400* 70.87 Profit of 16,867 on sale
2025-02-26SELL-2,540 71.960* 70.85 Profit of 179,959 on sale
2025-02-25SELL-2,142 71.450* 70.84 Profit of 151,739 on sale
2025-02-21SELL-2,646 73.300* 70.76 Profit of 187,235 on sale
2025-02-20SELL-4,699 74.710* 70.69 Profit of 332,171 on sale
2025-02-19SELL-4,914 74.670* 70.62 Profit of 347,008 on sale
2025-02-13SELL-5,292 76.000* 70.18 Profit of 371,416 on sale
2025-02-12SELL-1,764 75.820* 70.07 Profit of 123,602 on sale
2025-02-11SELL-1,134 70.910* 70.05 Profit of 79,439 on sale
2025-02-10SELL-126 71.100* 70.03 Profit of 8,824 on sale
2025-02-07SELL-2,646 70.350* 70.02 Profit of 185,280 on sale
2025-02-06SELL-126 70.990* 70.00 Profit of 8,820 on sale
2025-02-05SELL-378 72.100* 69.95 Profit of 26,442 on sale
2025-02-04SELL-1,260 71.330* 69.92 Profit of 88,101 on sale
2025-02-03SELL-1,512 71.380* 69.89 Profit of 105,669 on sale
2025-01-29SELL-2,286 71.130* 69.70 Profit of 159,342 on sale
2025-01-28SELL-2,413 72.560* 69.63 Profit of 168,013 on sale
2025-01-24SELL-254 68.990* 69.66 Profit of 17,693 on sale
2025-01-23SELL-254 68.930* 69.68 Profit of 17,698 on sale
2025-01-02SELL-1,015 72.590* 69.59 Profit of 70,637 on sale
2024-12-10SELL-248 73.390* 69.48 Profit of 17,231 on sale
2024-12-09BUY756 70.900* 69.43
2024-12-04BUY126 74.200* 69.09
2024-12-02SELL-476 70.530* 69.00 Profit of 32,844 on sale
2024-11-27BUY378 72.070* 68.65
2024-11-26SELL-504 71.550* 68.52 Profit of 34,534 on sale
2024-11-22SELL-889 70.480* 68.30 Profit of 60,714 on sale
2024-11-21SELL-254 70.380* 68.19 Profit of 17,321 on sale
2024-11-19BUY630 70.200* 68.00
2024-11-18SELL-3,051 69.890* 67.89 Profit of 207,143 on sale
2024-11-12BUY252 65.810* 68.02
2024-11-07BUY2,268 65.840* 68.43
2024-11-05BUY1,890 66.690* 68.83
2024-11-04SELL-504 66.470* 69.07 Profit of 34,811 on sale
2024-11-01SELL-5,334 67.540* 69.24 Profit of 369,326 on sale
2024-10-31BUY1,143 67.010* 69.52
2024-10-30SELL-375 68.630* 69.65 Profit of 26,117 on sale
2024-10-29SELL-8,375 69.370* 69.69 Profit of 583,668 on sale
2024-10-28SELL-250 68.520* 69.93 Profit of 17,481 on sale
2024-10-25SELL-9,250 69.380* 70.06 Profit of 648,078 on sale
2024-10-24SELL-1,000 70.350* 69.97 Profit of 69,967 on sale
2024-10-23SELL-125 70.610* 69.65 Profit of 8,706 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EW

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19406,40201,881,72721.6%
2025-09-18684,5201,1773,487,98119.6%
2025-09-17484,3222101,603,06530.2%
2025-09-16811,9538562,055,93739.5%
2025-09-15611,0121041,391,88243.9%
2025-09-12982,9281,1002,234,22744.0%
2025-09-11514,2348281,919,00926.8%
2025-09-10669,7051491,567,94142.7%
2025-09-09441,4930925,37547.7%
2025-09-08632,5876721,251,93950.5%
2025-09-05334,037300934,00635.8%
2025-09-04380,3180871,93143.6%
2025-09-03701,9434591,170,96659.9%
2025-09-02397,396531,208,87232.9%
2025-08-29397,628800844,31847.1%
2025-08-28604,08741,056,65357.2%
2025-08-27493,608822875,88656.4%
2025-08-26480,2680868,21355.3%
2025-08-25796,55601,181,25867.4%
2025-08-22552,73911,011,67854.6%
2025-08-21873,0447981,597,74254.6%
2025-08-20847,84738,6991,560,10554.3%
2025-08-19613,349331,256,57748.8%
2025-08-18668,7194391,642,75940.7%
2025-08-15369,455513826,72344.7%
2025-08-14514,2026,112864,59359.5%
2025-08-13567,8572991,347,26442.1%
2025-08-12547,77312,3161,428,27738.4%
2025-08-11487,82301,152,63042.3%
2025-08-08661,697201,224,45854.0%
2025-08-07669,9319821,297,46951.6%
2025-08-06880,0284131,551,65956.7%
2025-08-05661,93381,592,64941.6%
2025-08-04572,1652681,310,04443.7%
2025-08-01678,0285,6001,308,86351.8%
2025-07-31831,4012491,817,97545.7%
2025-07-301,305,0166932,481,80852.6%
2025-07-291,129,154582,399,22347.1%
2025-07-28684,1012,1112,276,89230.0%
2025-07-251,669,7529206,616,25925.2%
2025-07-24455,59302,607,89817.5%
2025-07-23444,64501,978,11022.5%
2025-07-22447,8835112,702,92516.6%
2025-07-21568,293271,249,72745.5%
2025-07-18590,448592,118,40227.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.